tiprankstipranks
Trending News
More News >
Forte Biosciences Inc. (FBRX)
NASDAQ:FBRX
US Market

Forte Biosciences (FBRX) Financial Statements

Compare
330 Followers

Forte Biosciences Financial Overview

Forte Biosciences's market cap is currently $401.99M. The company's EPS TTM is $-0.99; its P/E ratio is -7.22; Forte Biosciences is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-1.18. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -39.00K$ -9.00K$ 0.00$ -36.00K$ -54.00K
Operating Income$ -36.60M$ -32.49M$ -13.90M$ -21.49M$ -14.22M
EBITDA$ -35.44M$ -32.48M$ -13.86M$ -21.45M$ -46.43M
Net Income$ -35.48M$ -31.48M$ -13.86M$ -21.71M$ -46.49M
Balance Sheet
Cash & Short-Term Investments$ 58.37M$ 37.13M$ 41.10M$ 42.04M$ 58.77M
Total Assets$ 61.56M$ 38.98M$ 42.00M$ 43.31M$ 61.24M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -22.24M$ -11.96M$ -41.10M$ -42.04M$ -58.77M
Total Liabilities$ 9.08M$ 3.67M$ 3.18M$ 1.76M$ 2.26M
Stockholders' Equity$ 52.48M$ 35.31M$ 38.82M$ 41.55M$ 58.98M
Cash Flow
Free Cash Flow$ -30.78M$ -28.79M$ -8.19M$ -16.68M$ -18.42M
Operating Cash Flow$ -30.75M$ -28.71M$ -8.19M$ -16.68M$ -18.42M
Investing Cash Flow$ -35.99M$ 47.00K$ 0.00$ 0.00$ 3.58M
Financing Cash Flow$ 51.86M$ 24.68M$ 7.24M$ -44.00K$ 66.67M
Currency in USD

Forte Biosciences Earnings and Revenue History

Forte Biosciences Debt to Assets

Forte Biosciences Cash Flow

Forte Biosciences Forecast EPS vs Actual EPS